REVLIMID Clinical Results as Oral Treatment Regimen in Myelofibrosis Presented at the 47th American Society of Hematology Meeting
13th Dec 2005, 18:20 GMT
Celgene Corp announced that clinical data from a REVLIMID study in myelofibrosis were reported at an oral presentation during the 47th American Society of Hematology Meeting in Atlanta, GA.
REVLIMID Clinical Results as Oral Treatment Regimen in Myelofibrosis Presented at the 47th American Society of Hematology Meeting related news:
- REVLIMID Clinical Results as Oral Treatment Regimen in Chronic Lymphocytic Leukemia Presented at the 47th American Society of Hematology Meeting — Laboratory News from StratCenter.com
- REVLIMID Clinical Results as Oral Treatment Regimen in Newly Diagnosed Multiple Myeloma Presented at the 47th American Society of Hematology Meeting — Pharmaceuticals News from StratCenter.com
- REVLIMID(R) Clinical Results as Oral Treatment Regimen in Myelofibrosis Presented at the 47th American Society of Hematology Meeting — PR Newswire: All Releases
- REVLIMID(R) Clinical Results as Oral Treatment Regimen in Newly Diagnosed Multiple Myeloma Presented at the 47th American Society of Hematology Meeting — PR Newswire: All Releases
- BioCryst Announces Presentation of Fodosine Data During the 47th Annual Meeting and Exposition of the American Society Of Hematology — Laboratory News from StratCenter.com
- Ascenta AT-101 Data Presented at the American Society of Hematology 47th Annual Meeting and Exposition in Atlanta, GA — Bio-Technology News from StratCenter.com
- Immunomedics Reports Humanized Anti-CD20 Antibody Appears Safe and Active in Non-Hodgkin's Lymphoma — Laboratory News from StratCenter.com
- Cephalon Oncology Reports Clinical Response to CEP-701 Correlates With Targeted Inhibition of FLT3 Mutation in Acute Myelogenous Leukemia — Radiology News from StratCenter.com
- Dacogen Injection Data Presented at American Society of Hematology Annual Meeting — Laboratory News from StratCenter.com
- ASH meeting highlights — OnMedica Latest News
Latest news from Laboratory News from StratCenter.com:
- Abstract Evaluating QUADRAMET for Multiple Myeloma Presented erican Society of Hematology Annual Meeting
- QIAGEN Introduces Novel Technology for Customized RNAi Assay Products
- Stratagene Reports Q3 Results
- Viking Systems Appoints Dr Michael Manyak to Its Board
- Soliant Health To Exhibit at the American Speech-Language-Hearing Assoc Conference
- Sysmex America Awarded Contract to Service VA Med Cntrs in Midwest States
- Ronald D Luff, MD, Recognized By the American Society of Cytopathology for Groundbreaking Work in Diagnosis of Cervical Disease
- INNOVIVE Pharmaceuticals Reports Q3 Results
- Launch of 'Egg Banking' Program Breaks New Ground as 1st Program of Its Kind in NC
- Global Care Quest Announces ICIS 5